Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1-month vs 3-month dual antiplatelet therapy after PCI in high bleeding risk patients
TCTR20211024003Phase 3Recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Jul 2021
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin + P2Y12 antagonist in coronary arteriosclerosis, sponsored by Faculty of Medicine, Chiang Mai University. Started Jul 2021; status: recruiting.
02
Drugs
aspirin + P2Y12 antagonist
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on TCTR20211024003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211024003.